词条 | PSB-10 |
释义 |
}}{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 444488867 | IUPAC_name = (8R)-ethyl-4-methyl-2-(2,3,5-trichlorophenyl)-4,5,7,8-tetrahydro-1H-imidazo[2,1-i]purin-5-one | image = PSB-10.svg | width = 240 | tradename = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | bioavailability = | protein_bound = | metabolism = | excretion = | IUPHAR_ligand = 5619 | CAS_number_Ref = {{cascite|changed|??}} | CAS_number = 591771-91-4 | ATC_prefix = | ATC_suffix = | PubChem = 10318703 | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank = | ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} | ChemSpiderID = 8494167 | ChEMBL_Ref = {{ebicite|changed|EBI}} | ChEMBL = 1562432 | C=16 | H=14 | Cl=3 | N=5 | O=1 | molecular_weight = 400.690 g/mol | smiles = Clc2cc(Cl)cc(c2Cl)C(=N3)NC1C3N(C)C(=O)N4C1=NC(C4)CC | StdInChI_Ref = {{stdinchicite|changed|chemspider}} | StdInChI = 1S/C16H14Cl3N5O/c1-3-8-6-24-15(20-8)12-14(23(2)16(24)25)22-13(21-12)9-4-7(17)5-10(18)11(9)19/h4-5,8H,3,6H2,1-2H3,(H,21,22)/t8-/m1/s1 | StdInChIKey_Ref = {{stdinchicite|changed|chemspider}} | StdInChIKey = YYDHUJWLNPIBDS-MRVPVSSYSA-N | synonyms = PSB-10 | melting_point = | melting_high = }}PSB-10 is a drug which acts as a selective antagonist[1] for the adenosine A3 receptor (ki value at human A3 receptor is 0.44 nM), with high selectivity over the other three adenosine receptor subtypes (ki values at human A1, A2A and A2B receptors are 4.1, 3.3 and 30 µM). Further pharmacological experiments in a [35S]GTPγS binding assay using hA3-CHO-cells indicated that PSB-10 acts as an inverse agonist (IC50 = 4 nM). It has been shown to produce antiinflammatory effects in animal studies.[2] Simple xanthine derivatives such as caffeine and DPCPX have generally low affinity for the A3 subtype and must be extended by expanding the ring system and adding an aromatic group to give high A3 affinity and selectivity.[3] The affinity towards adenosine A3 subtype was measured against the radioligand PSB-11.[4] References1. ^{{cite journal | vauthors = Ozola V, Thorand M, Diekmann M, Qurishi R, Schumacher B, Jacobson KA, Müller CE | title = 2-Phenylimidazo[2,1-i]purin-5-ones: structure-activity relationships and characterization of potent and selective inverse agonists at Human A3 adenosine receptors | journal = Bioorg Med Chem | volume = 11 | issue = 3 | pages = 347–56 | year = 2003 | pmid = 12517430 | doi = 10.1016/S0968-0896(02)00456-X | url = | issn = }} {{Adenosinergics}}{{nervous-system-drug-stub}}2. ^{{cite journal | vauthors = Bilkei-Gorzo A, Abo-Salem OM, Hayallah AM, Michel K, Müller CE, Zimmer A | title = Adenosine receptor subtype-selective antagonists in inflammation and hyperalgesia | journal = Naunyn-Schmiedeberg's Archives of Pharmacology | volume = 377 | issue = 1 | pages = 65–76 |date=March 2008 | pmid = 18188542 | doi = 10.1007/s00210-007-0252-9 | url = | issn = }} 3. ^{{cite journal | author = Müller CE | title = Medicinal chemistry of adenosine A3 receptor ligands | journal = Current Topics in Medicinal Chemistry | volume = 3 | issue = 4 | pages = 445–62 | year = 2003 | pmid = 12570761 | doi = 10.2174/1568026033392174| url = http://www.bentham-direct.org/pages/content.php?CTMC/2003/00000003/00000004/0008R.SGM | issn = }} 4. ^{{cite journal | vauthors = Müller CE, Diekmann M, Thorand M, Ozola V | title = [(3)H]8-Ethyl-4-methyl-2-phenyl-(8R)-4,5,7,8-tetrahydro-1H-imidazo[2,1-i]-purin-5-one ([(3)H]PSB-11), a novel high-affinity antagonist radioligand for human A(3) adenosine receptors. | journal = Bioorg Med Chem Lett | volume = 12 | issue = 3 | pages = 501–3 | year = 2002 | pmid = 11814828 | doi = 10.1016/S0960-894X(01)00785-5 | url = | issn = }} 4 : Chloroarenes|Purines|Lactams|Adenosine receptor antagonists |
随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。